Jeremy Burrows

VP, Head of Discovery

Switzerland

Research Interests

Explore related searches

Professors in Switzerland

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (10)

Boris Striepen

Professor

University of Pennsylvania

UNITED STATES

View details

Philipp Olias

Director / Professor

Justus Liebig University

GERMANY

View details

David Fidock

Professor

Columbia University

UNITED STATES

View details

Jair Siqueira-Neto

Assistant Professor

University of California, San Diego

UNITED STATES

View details

Joerg J. Moehrle

VP, Head of Translational Medicine

SWITZERLAND

View details

Alan Cowman

University of Melbourne

AUSTRALIA

View details

Wesley Van Voorhis

Professor

University of Washington

UNITED STATES

View details

Jonathan Spector

Novartis Institutes for BioMedical Research Inc

UNITED STATES

View details

Susan Charman

MONASH UNIVERSITY

AUSTRALIA

View details

Elizabeth Winzeler

Professor

University of California, San Diego

UNITED STATES

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jeremy Burrows

Research Interests

Explore related searches

Contact this professor

Articles (10)

Antimalarial drug discovery: progress and approaches

Safe and effective treatments are needed for cryptosporidiosis, a truly neglected tropical disease

Development and application of a PBPK modeling strategy to support antimalarial drug development

The Parasite Reduction Ratio (PRR) Assay Version 2: Standardized Assessment of Plasmodium falciparum Viability after Antimalarial Treatment In Vitro

Discovery and Characterization of Potent, Efficacious, Orally Available Antimalarial Plasmepsin X Inhibitors and Preclinical Safety Assessment of UCB7362

Multistage and transmission-blocking tubulin targeting potent antimalarial discovered from the open access MMV pathogen box

Optimized Pyridazinone Nutrient Channel Inhibitors Are Potent and Specific Antimalarial Leads

Screening the pandemic response box identified benzimidazole carbamates, Olorofim and ravuconazole as promising drug candidates for the treatment of eumycetoma

The Antifungal Itraconazole Is a Potent Inhibitor of Chikungunya Virus Replication

Volunteer infection studies accelerate the clinical development of novel drugs against malaria

Collaborators (10)

Boris Striepen

Philipp Olias

David Fidock

Jair Siqueira-Neto

Joerg J. Moehrle

Alan Cowman

Wesley Van Voorhis

Jonathan Spector

Susan Charman

Elizabeth Winzeler

Make your next move.